http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001051373-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
filingDate | 1999-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf8a1cd173cd7a4496beadb6a140ff36 |
publicationDate | 2001-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2001051373-A1 |
titleOfInvention | T-cell clones expressing anti-hiv-1 factors |
abstract | Certain clones of CD4+ cells from an HIV-infected patient who has not progressed to AIDS exhibit the ability to inhibit HIV replication at a stage subsequent to entry of the HIV-1 virus into the cell and integration of viral cDNA into the cellular genome. These cells secrete a soluble factor different from known cytokines and chemokines that can, inhibit infection of lymphocytes by SI HIV-1. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018006-B2 |
priorityDate | 1999-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 193.